$4.930
-0.088 (-1.79%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de CSBR por análisis de gráficos similares
Alphio's CSBR stock price prediction model matches the current Champions Oncology Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $4.90 (-0.56%). The 1-week path is $4.97 (+0.87%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Champions Oncology Inc?
CSBR is not a strong buy at the moment due to its current price of $4.93, which is significantly lower than its 200-day moving average of $6.13, indicating a bearish trend. The RSI is at 40.16, suggesting the stock is nearing oversold territory but not yet a clear buy signal. Additionally, the forward P/E ratio of 22.88 indicates that the stock may be overvalued based on future earnings expectations. The main risk is the declining net income, with a reported net income of -667,000 USD in Q4 2026, reflecting ongoing profitability challenges.
CSBR cerró en $4.93 el Friday, tras bajar -1.79%
Champions Oncology Inc (CSBR) last closed at $4.93, losing -1.79%. These facts feed the 1-day and 1-week CSBR price prediction above.
Consenso de analistas
Champions Oncology Inc (CSBR): 1 comprar, 0 mantener, 0 vender. Perspectiva: Strong Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Factores de la previsión
Los factores de la previsión de Champions Oncology Inc (CSBR) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de CSBR, ordenadas por similitud.
Análisis de estacionalidad de CSBR
Historically the probability of a positive August return for CSBR is 0.00%. January offers the highest probability of a positive month at 93.44%, while May is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de CSBR
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Aug 2026 | $5.98 | $6.99 | $7.80 | +41.71% |
| Sep 2026 | $4.94 | $6.39 | $6.64 | +29.56% |
| Oct 2026 | $5.95 | $7.20 | $7.64 | +46.10% |
| Nov 2026 | $8.15 | $8.46 | $9.50 | +71.57% |
| Dec 2026 | $6.97 | $7.86 | $7.89 | +59.41% |
En 2026, se proyecta que Champions Oncology Inc (CSBR) oscile entre $4.94 y $9.50.
Previsión mensual de Champions Oncology Inc para 2026
En Aug de 2026, se proyecta que Champions Oncology Inc promedie $6.99, con un mínimo de $5.98 y un máximo de $7.80.
En Sep de 2026, se proyecta que Champions Oncology Inc promedie $6.39, con un mínimo de $4.94 y un máximo de $6.64.
En Oct de 2026, se proyecta que Champions Oncology Inc promedie $7.20, con un mínimo de $5.95 y un máximo de $7.64.
En Nov de 2026, se proyecta que Champions Oncology Inc promedie $8.46, con un mínimo de $8.15 y un máximo de $9.50.
En Dec de 2026, se proyecta que Champions Oncology Inc promedie $7.86, con un mínimo de $6.97 y un máximo de $7.89.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.